Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression - Wang, Wanchen; Kumegawa, Kohei; Chapman, Owen S.; Shiraishi, Ryo; Xiao, Zhize; Okonechnikov, Konstantin; Sun, Yang; Pfister, Stefan; Feng, Weijun; Uesaka, Naofumi; Hoshino, Mikio; Takahashi, Satoru; et al. (Cell reports, 2025)
Online verfügbar: 19. Mai 2025, Artikelversion: 27. Mai 2025